Lower Blood Pressure Targets Reduce Heart Risk
較低的血壓目標可降低心臟病風險
In recent years, modern cardiovascular medicine has embraced a new philosophy: lower blood pressure targets significantly reduce heart risk.
近年來，現代心血管醫學採納了一種新的理念：較低的血壓目標可顯著降低心臟病風險。
Driven by the landmark SPRINT trial, which studied over 9,000 adults, evidence shows that an intensive systolic blood pressure target of under 120 mm Hg leads to a 25% reduction in major cardiovascular events like heart attacks and strokes.
在具有里程碑意義的SPRINT臨床試驗推動下—該研究涵蓋了超過9,000名成年人—證據顯示，將收縮壓強制控制在120 mm Hg以下，可使心臟病發作和中風等重大心血管事件減少25%。
Consequently, international guidelines have shifted, with many now recommending a target of under 130/80 mm Hg for most adults.
因此，國際指引已經調整，許多組織現已建議將大多數成年人的血壓控制在130/80 mm Hg以下。
Beyond heart health, lower systolic levels have been linked to a reduced risk of cognitive decline.
除了心臟健康外，較低的收縮壓也與降低認知能力下降的風險有關。
While this 'lower is better' approach offers clear benefits, clinicians must weigh them against potential risks like dizziness or kidney injury, particularly in older patients.
儘管這種「越低越好」的方法帶來明顯益處，但臨床醫師必須權衡潛在風險，如頭暈或腎臟損傷，特別是針對高齡患者。
Success relies on individualized care, accurate monitoring, and a combination of medication and healthy lifestyle changes, such as the DASH diet and regular exercise.
成功的關鍵在於個人化治療、精確監測，以及藥物治療與健康生活方式改變的結合，例如DASH飲食和規律運動。
By prioritizing consistent blood pressure management, patients can significantly lower their long-term health risks.
透過優先重視持續的血壓管理，患者能夠顯著降低其長期健康風險。
